drugset / Trial / NCT03790215

Dydrogesterone in the Treatment of Endometrial Polyps

NCT03790215

Phase 4 Completed 60 enrolled Peking Union Medical College Hospital
NaSingle-groupOpen-labelTreatment

Summary

This study is intended to observe the therapeutic effect of dydrogesterone on endometrial polyps and provide a reference for clinical treatment.

Timeline

Start
2019-02-01
Primary completion
2019-09-30
Completion
2019-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Dydrogesterone Other / unclassified 10 mg Oral

Indications